首页 | 本学科首页   官方微博 | 高级检索  
检索        

卡铂联合化疗治疗老年非小细胞肺癌剂量探讨
引用本文:殷铁军,刘菁菁,杨剑霞,胡长耀.卡铂联合化疗治疗老年非小细胞肺癌剂量探讨[J].肿瘤防治研究,2004,31(11):706-708.
作者姓名:殷铁军  刘菁菁  杨剑霞  胡长耀
作者单位:1. 430030,武汉,华中科技大学同济医学院附属同济医院综合医疗科
2. 430030,武汉,华中科技大学同济医学院附属同济医院肿瘤科
摘    要: 目的探讨老年非小细胞肺癌患者联合化疗时卡铂按AUC=5mg/ml·min(AUC,areaundertheconcentrationtimecurve)的剂量是否适宜。方法33例老年晚期非小细胞肺癌患者采用Taxol+CBP、Gemzar+CBP、NVB+CBP方案化疗,卡铂用药剂量按AUC=5的水平给药。全部患者共完成73周期化疗。每周期化疗前后对患者的化疗毒副反应及生活质量变化进行评估。结果骨髓毒副反应常见且较重,中性粒细胞出现Ⅲ/Ⅳ级副反应为47.9%(35/73)、血小板出现Ⅲ/Ⅳ级副反应为28.8%(21/73)。其余毒副反应不重。生存质量评分(依据国内肿瘤患者生存质量评分标准)平均下降6.5分。结论老年非小细胞肺癌患者联合化疗时,卡铂按AUC=5的剂量水平用药毒副反应较重,且对生存质量有不利影响,可能与剂量偏大有关。

关 键 词:老年患者  非小细胞肺癌  卡铂  曲线下面积  生存质量
文章编号:1000-8578(2004)11-0706-03
收稿时间:2004-2-17
修稿时间:2004-4-1

A Study on Dose Level of Carboplatin Combined Chemotherapy in Treatment of Elder Non-small Cell Lung Cancer
YIN Tie jun,LIU Qing qing,YANG Jian xia,HU Chang yao.A Study on Dose Level of Carboplatin Combined Chemotherapy in Treatment of Elder Non-small Cell Lung Cancer[J].Cancer Research on Prevention and Treatment,2004,31(11):706-708.
Authors:YIN Tie jun  LIU Qing qing  YANG Jian xia  HU Chang yao
Institution:YIN Tie jun,LIU Qing qing,YANG Jian xia,HU Chang yao 1.Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China,2.Department of Oncology
Abstract:Objective Preliminarily to determine whether it was appropriate for elder patients with non small cell lung cancer to be treated by carboplatin at AUC=5 mg/ml·min level during combined chemotherapy.Methods 33 cases of elder patients with non small cell lung cancer in advanced stage had received 73 cycles combination chemotherapy. Chemotherapy schemes included Taxol+CBP,Gemzar+CBP and NVB+CBP. The dose of carboplatin was at AUC=5 mg/ml·min level (AUC, area under the concentration time curve). Side effects an...
Keywords:Senile patient  Non small cell lung cancer  Carboplatin  Area under the curve  Quality of life
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号